Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression
In Vivo · 2023
DOI: 10.21873/invivo.13332 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Si-Hyong Jang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea. Hauptthemen laut MEDLINE: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
- Department of Pathology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea mhoh0212@hanmail.net.
Zitieren
APA
Jang, S. H., Cho, H. D., Lee, J. H., & Oh, M. H. (2023). Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression. In Vivo. https://doi.org/10.21873/invivo.13332
Vancouver
Jang SH, Cho HD, Lee JH, Oh MH. Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression. In Vivo. 2023. doi:10.21873/invivo.13332
BibTeX
@article{Jang2023,
author = {Jang, Si-Hyong and Cho, Hyun Deuk and Lee, Ji-Hye and Oh, Mee-Hye},
title = {Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13332}
}
EUVIMED